Cleared Traditional

K994278 - ACCESS OSTASE IMMUNOENZYMETRIC ASSAY

K994278 is the FDA 510(k) clearance for ACCESS OSTASE IMMUNOENZYMETRIC ASSAY by Beckman Coulter, Inc.. It is a Class 2 Chemistry device (product code CIN) cleared through the Traditional 510(k) pathway after a 99-day FDA review.

K994278 · Beckman Coulter, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2000
Decision
99d
Days
Class 2
Risk

K994278 is an FDA 510(k) clearance for the ACCESS OSTASE IMMUNOENZYMETRIC ASSAY. Classified as Electrophoretic Separation, Alkaline Phosphatase Isoenzymes (product code CIN), Class II - Special Controls.

Submitted by Beckman Coulter, Inc. (San Diego, US). The FDA issued a Cleared decision on March 28, 2000 after a review of 99 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1050 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Beckman Coulter, Inc. devices

Submission Details

510(k) Number K994278 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 1999
Decision Date March 28, 2000
Days to Decision 99 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d slower than avg
Panel avg: 88d · This submission: 99d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIN Electrophoretic Separation, Alkaline Phosphatase Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIN Electrophoretic Separation, Alkaline Phosphatase Isoenzymes

All 17
Devices cleared under the same product code (CIN) and FDA review panel - the closest regulatory comparables to K994278.
Access Ostase
K232904 · Beckman Coulter · Apr 2024
IDS-iSYS Ostase BAP
K200475 · Immunodiagnostic Systems , Ltd. · Sep 2020
SPIFE 2000/3000 ALP 40, 20
K020625 · Helena Laboratories · May 2002
TANDEM-MP OSTASE IMMUNOENZYMETRIC ASSAY
K972666 · Hybritech, Inc. · Sep 1997
OPUS BONE ALP
K964764 · Behring Diagnostics, Inc. · Jan 1997
TANDEM-R OSTASE IMMUNORADIOMETRIC ASSAY
K961573 · Hybritech, Inc. · Aug 1996